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Relationship between inﬂammatory markers and
visceral obesity in obese and overweight Korean
adults
An observational study
Ju-Yeon Yu, MDa, Won-Jun Choi, MDa, Hye-Sun Lee, PhDb, Ji-Won Lee, MD, PhDa,
∗
Abstract
Obesity is now considered a state of chronic low-grade inﬂammation. We investigated the relationship between several inﬂammatory
markers and body composition for identifying patients with an increased risk of visceral obesity and compared the predictive values of
inﬂammatory indices in visceral obesity.
Six hundred individuals who received health checkups for obesity-related risk factors in Severance Hospital between January 2008
andMarch 2017 were included in our study. Serum inﬂammatory markers, such as white blood cell (WBC), high-sensitivity C-reactive
protein (hsCRP), neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR) levels were assessed. Intra-abdominal
visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) areas were measured with computed tomography. We
performed analysis of covariance, trend analysis, Steiger’s Z tests, and multiple linear regression analysis to investigate associations
between abdominal adiposity indices and inﬂammatory markers.
Pearson’s correlation analysis revealed a stronger association of VATwithWBC counts (r=0.157, P< .001) thanwith levels of NLR
(r=0.108, P= .11; Steiger’s Z test, P‡= .04) and PLR (r=0.036, P= .39; Steiger’s Z test, P‡= .003). WBC and hsCRP levels linearly
increased with VAT area (overall P< .001 and trend P< .001) and VAT/SAT ratio (overall P= .001 and trend P= .002; overall P< .001
and trend P< .001, respectively) but linearly decreased with SAT (overall P= .02 and trend P= .17; overall P= .03 and trend P= .01,
respectively). Visceral adipose tissue area wasmore highly associated withWBC and hsCRP levels than with NLR and PLR. Only VAT
area was signiﬁcantly associated with WBC, hsCRP, and NLR levels after adjusting for confounding variables.
We found that VAT, but not SAT area is independently associated with several inﬂammatory markers. WBC and hsCRP are more
strongly correlated with VAT compared with NLR and PLR. Thus, WBC and hsCRP could be useful parameters for identifying
individuals at risk for visceral obesity and cardiometabolic diseases.
Abbreviations: BMI = body mass index, HDL = high-density lipoprotein, hsCRP = high-sensitivity C-reactive protein, LDL = low-
density lipoprotein, MS = metabolic syndrome, NLR = neutrophil-lymphocyte ratio, PLR = platelet-lymphocyte ratio, SAT =
subcutaneous adipose tissue, TG= triglycerides, VAT = visceral adipose tissue, V/S ratio = VAT/SAT ratio, WBC =white blood cells,
WC = waist circumference.
Keywords: hsCRP, inﬂammatory marker, visceral fat, WBC
1. Introduction
Chronic low-grade inﬂammation has been documented to play
regulatory roles in various metabolic diseases and cardiovascular
disease (CVD) under both physiological and pathophysiological
conditions.[1] Obesity is an important cause of chronic diseases
and is also considered a state of chronic low-grade inﬂammation.
The excessive accumulation of fat in adipose tissue recruits
macrophages[1] and leads to increased production of many pro-
inﬂammatory cytokines and chemokines, including tumor
necrosis factor-a, monocyte-chemoattractant protein 1, and
interleukin-6 that can attract inﬂammatory cells.[2] Finally, this
obesity-mediated adipose tissue remodeling causes metabolic
dysfunction such as insulin resistance[3] and obesity-related
systemic diseases.[4] Therefore, the evaluation of an individual’s
inﬂammatory status could be helpful for predicting obesity-
related health problems and decrease chronic disease burden in
this population.
Several inﬂammatory biomarkers, such as high-sensitivity
C-reactive protein (hsCRP) and white blood cell (WBC) count,
have been used to predict the risk of coronary heart disease and
other age-related degenerative diseases.[5,6] These markers[7,8] are
also associated with the degree of obesity expressed as body
mass index (BMI),[9] waist circumference (WC),[10,11] and waist-
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hip-ratio.[12] However, these body composition variables cannot
distinguish visceral adipose tissue (VAT) from subcutaneous
adipose tissue (SAT) and are limited for predicting CVD.[13]
Visceral adipose tissue area has a stronger association with
cardiometabolic risk than SAT area,[14] and although the
pathological mechanisms linking VAT with its comorbidities
are multifactorial, altered secretion of pro-inﬂammatory adipo-
kines and a succession of inﬂammatory processes in VAT are
considered primary contributing factors for CVD.[13]
Recently, neutrophil-lymphocyte and platelet-lymphocyte
ratios (NLR[15,16] and PLR[17]) have emerged as reliable
prognostic parameters in many cancers and inﬂammatory
diseases. However, there has been controversy about the
relationship between NLR, PLR, and body composition[18]
and more studies are required.
Thus, we investigated the relationship between various serum
inﬂammatory markers (hsCRP, WBC, NLR, and PLR) and body
composition (VAT and SAT) accurately measured by abdominal
computed tomography (CT) scans and compared the predictive
values of inﬂammatory biomarker values in visceral obesity. We
also used the VAT area to SAT area ratio (V/S ratio) at the L4–5
level in order to estimate the likelihood of visceral obesity in each
subject (visceral V/S ratio ≥0.4; subcutaneous V/S ratio <0.4[19])
and evaluate the correlation with surrogate inﬂammatory marker
levels.
2. Materials and methods
2.1. Study sample
Our study subjects were selected from 474,616 patients who
visited the Severance Health promotion center or the Department
of FamilyMedicine in Severance Hospital, in Seoul, South Korea,
for health checkups between January 2008 and March 2017.
Exclusion criteria were:
(1) aged under 19 years or over 65 years;
(2) non-Korean;
(3) no CT scan to measure abdominal VAT;
(4) diagnosis of hypertension, diabetes, dyslipidemia, thyroid
dysfunction, or cancer; and
(5) abnormal values for hsCRP (≥6.0mg/L[20]) or WBC (4,000
or ≥10,000 cells/mL[21]).
After applying these criteria, 600 eligible adults were included
in our study (Fig. 1), which complied with the Declaration of
Helsinki and was approved by the Institutional Review Board of
Severance Hospital.
Hypertension was deﬁned as a history of taking anti-
hypertensive medication, a resting systolic blood pressure (BP)
≥140mmHg, or a resting diastolic BP ≥90mmHg during at least
two measurements. Diabetes mellitus was deﬁned as a fasting
plasma glucose level ≥126mg/dL or a history of taking oral
hypoglycemic agents or insulin. Dyslipidemia was deﬁned as a
total serum cholesterol level≥240mg/dL, low-density lipoprotein
(LDL) cholesterol ≥160mg/dL, or a history of taking lipid-
lowering drugs.
2.2. Anthropometrics and biochemical variables
Body mass index was deﬁned as body weight divided by the
square of body height (kg/m2), andWC (cm) was measured at the
umbilicus level at the narrowest point between the lower border
of the rib cage and the uppermost border of the iliac crest during
normal expiration while the patient was standing. Systolic and
diastolic BP (mm Hg) was measured after 10min of resting in a
sitting position and was recorded as the average of three
consecutive readings.
Intra-abdominal VAT and SAT areas were measured via fat
measurement CT (Tomoscan 350, Philips; Mahwah, NJ, USA) as
described previously.[22] Fat measurement CT is an imaging test
widely used in clinical studies to assess the visceral and
subcutaneous fat most accurately and conveniently with fewer
slices and lesser radiation than typical abdomen and pelvis CT
(APCT). The VAT and SAT areas were measured at the L4–5
level with 3mm slice thickness in the supine position. We
quantiﬁed the VAT area by deﬁning the intra-abdominal cavity at
the internal side of the abdominal and oblique muscle walls
Figure 1. Patient selection ﬂow chart. hsCRP=high-sensitivity C-reactive protein, WBC=white blood cell.
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surrounding the cavity and the posterior aspect of the vertebral
body. The V/S ratio (VAT area to SAT area ratio) at the L4–5[23]
was then calculated. All measurements were veriﬁed by a skilled
radiologist who was blinded to the patient data (see supplement
ﬁgure, which illustrates the measurement of the VAT area, SAT
area, and V/S ratio, http://links.lww.com/MD/C857).
Lifestyle factors, including smoking status (pack-years) and
alcohol consumption (average number of drinking days per week
within the last year), were self-reported.
Blood samples were collected after an overnight fast (>12h).
Serum levels of glucose, total cholesterol, triglycerides (TG), high-
density lipoprotein (HDL) cholesterol, LDL cholesterol, and
hsCRP were measured with a Hitachi 7600 Automatic analyzer
(High-Technologies Corporation, Hitachi; Tokyo, Japan). Total
differential blood counts were recorded with an automatic blood
counter system (ADVIA 120, Bayer; Whippany, NJ, USA).
Patient NLR and PLR were calculated by dividing the total
neutrophil count by the lymphocyte count and the total platelet
count by the lymphocyte count, respectively.
Metabolic syndrome was deﬁned according to the National
Cholesterol Education Program Adult Treatment Panel III
criteria. Patients who met at least two of the following four
criteria were diagnosed with metabolic syndrome:
(1) abdominal obesity (WC >102cm in men and >88cm in
women);
(2) high TG levels (>150mg/dL) or receiving treatment for
dyslipidemia;
(3) low HDL levels (<40mg/dL for men and <50mg/dL for
women); and
(4) high BP (systolic >130mm Hg and/or diastolic >85mm Hg)
or using an anti-hypertensive medication.
2.3. Statistical analysis
Datawere expressed asmeans and standard deviations.Normality
of the variables was assessed with Kolmogorov–Smirnov tests. To
examine the association among surrogate inﬂammatory markers
(WBC, hsCRP, NLR, and PLR), metabolic parameters, and
abdominal fat composition, analysis of covariance (ANCOVA)
and trend analysis were performed after adjustments for age, sex,
and BMI. The differences in absolute correlation coefﬁcients
between inﬂammatory markers and abdominal VAT area were
determined using Steiger’sZ testswhile calculating the dependency
for two correlation coefﬁcients.[24] Additionally, multiple linear
regression analysis with the Enter method was used to assess
independent associations between abdominal adiposity indices
and inﬂammatory markers. Statistical analysis was performed
using SPSS version 20 (IBM Corp.; Armonk, NY, USA), and P
values less than .05 indicated statistical signiﬁcance.
3. Results
The patients’ demographic and clinical characteristics are shown
in Table 1. The mean age was 37.4 years, and mean BMI was
27.9. The mean WBC count was 6400cells/mL, and mean NLR
and PLR were 1.7 and 8.2, respectively. The mean serum hsCRP
concentration was 1.5mg/L.
3.1. Associations between body composition and
metabolic parameters
Table 2 shows the relationship between metabolic parameters
and abdominal fat composition tertiles by ANCOVA and trend
analysis. Diastolic BP, fasting glucose, total cholesterol, TG,
LDL, and the mean numbers of metabolic syndrome criteria
linearly increased with VAT and V/S values after adjusting
covariates (overall P< .05 and trend P< .05). In contrast, HDL
levels exhibited an inverse relationship with VAT area (overall
P< .001 and trend P< .001) and V/S (overall P< .001 and trend
P< .001).
3.2. Associations between abdominal fat composition and
inﬂammatory markers
Figure 2 displays the mean levels of inﬂammatory markers by
abdominal fat composition tertiles after adjusting for age, sex,
and BMI. Covariate-adjusted mean WBC and hsCRP levels
linearly increased with VAT area (overall P< .001 and trend
P< .001) and V/S (overall P= .001 and trend P= .002; overall
P< .001 and trend P< .001, respectively).
However, covariate-adjusted mean hsCRP levels linearly
decreased with SAT area (overall P= .03 and trend P= .01).
Mean WBC counts showed similar results (overall P= .02 and
Table 1
Demographic and clinical characteristics of study patients (n=
600).
Variables Mean values
∗
Age (years) 37.4±12.7
Sex
Male 145 (24%)
Female 455 (76%)
BMI (kg/m2) 27.9±4.7
WC (cm) 93.4±11.2
Abdominal fat tissue areas (cm2)
VAT 104.5±50.7
SAT 247.4±130.2
V/S ratio 0.7±1.0
Blood pressure (mm Hg)
Systolic 122.0±12.7
Diastolic 73.1±8.3
Metabolic variables
Fasting glucose (mg/dL) 92.9±12.9
Total cholesterol (mg/dL) 191.2±36.4
TG (mg/dL) 117.2±69.8
HDL cholesterol (mg/dL) 51.2±12.4
LDL cholesterol (mg/dL) 116.2±31.3
Non-HDL cholesterol (mg/dL) 139.8±37.0
TG/HDL ratio 3.93±1.20
LDL/HDL ratio 2.42±0.95
Inﬂammatory markers
WBC count (K/mL) 6.4±1.7
Neutrophils (%) 55.3±8.6
Lymphocytes (%) 35.8±17.5
NLR 1.7±0.8
hsCRP (mg/L) 1.5±1.3
PLR 8.2±3.2
Smoking (pack-years) (n=522)† 1.2±4.7
Drinking (days per week) (n=522)† 0.4±1.0
MS criteria numbers 1.6±1.1
Smoking and drinking variables were deﬁned as total smoking pack-years and average number of
drinking days per week within the last year.
BMI=body mass index, HDL=high-density lipoprotein, hsCRP=high-sensitivity C-reactive protein,
LDL= low-density lipoprotein, MS=metabolic syndrome, NLR=neutrophil-lymphocyte ratio, PLR=
platelet-lymphocyte ratio, SAT= subcutaneous adipose tissue, TG= triglycerides, V/S ratio=VAT/SAT
ratio, VAT= visceral adipose tissue, WBC=white blood cells, WC=waist circumference.
∗
Data are expressed as means± standard deviations or percentages.
† Smoking and drinking variables included data of 522 individuals without missing data.
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trend P= .17), although no signiﬁcant differences were noted for
mean NLR and PLR levels in relation to VAT and V/S values.
3.3. Comparison of correlation coefﬁcients of
inﬂammatory markers and VAT area
Weperformed this comparison using Steiger’sZ test with amodel
adjusted for age, sex, and BMI. Pearson’s correlation analysis
revealed a stronger association of VAT with WBC counts (r=
0.157, P< .001) than with levels of NLR (r=0.108, P= .11;
Steiger’s Z test, P‡= .04) and PLR (r=0.036, P= .39; Steiger’s Z
test, P‡= .003). However, the correlation coefﬁcients for WBC
and hsCRP levels (r=0.159, P< .001, Steiger’s Z test, P‡= .97)
and VAT area were not signiﬁcantly different.
3.4. Independent associations between inﬂammatory
markers and abdominal fat compositions
Table 3 shows the independent associations of inﬂammatory
markers with abdominal fat compositions using multivariate-
adjusted models from the Enter method for multiple linear
regression analysis. VAT area showed signiﬁcant associations
with levels of WBC (P= .001), hsCRP (P< .001), and NLR
(P= .03) after adjusting for confounding variables (age, sex, BMI,
diastolic BP, HDL, LDL, and smoking status). V/S ratios were
signiﬁcantly associated with WBC (P= .03) but not with hsCRP
levels (P= .18) after adjusting for the same confounding
variables. We observed no signiﬁcant association between SAT
area and inﬂammatory markers after adjusting for covariates.
4. Discussion
We found that levels of certain surrogate inﬂammatory markers
(WBC, hsCRP, and NLR) were independently associated with
VAT, but not with SAT. Moreover, VAT area was more highly
associated with WBC and hsCRP levels than with NLR or PLR
after calculating correlation coefﬁcients using Steiger’s Z test.
A large body of evidence indicates that the regional distribution
of body fat, rather than overall obesity, is linked to systemic
inﬂammation,[25] insulin resistance, and oxidative stress.[26]
Visceral fat is more metabolically active than subcutaneous
fat[27] and affects the development of metabolic disturbances
by contributing to the pro-inﬂammatory milieu (“meta-
inﬂammation”[28]). In previous studies,[25,29] increased VAT
showed a signiﬁcant relationship with systemic inﬂammation. In
line with the former study,[29] this study also assessed the
association between various markers of systemic inﬂammation
and visceral obesity.
Although the precise role of visceral fat in metabolic
disturbance is unknown, various adipokines[30] and pro-
inﬂammatory cytokines secreted by visceral adipocytes may be
involved in altered metabolism.[31] Indeed, in vitro experiments
have shown that VAT-derived adipocytes secrete more pro-
inﬂammatory cytokines than SAT-derived adipocytes.[32] Also, as
the central obesity level increases, the expression of IL-6 and
MCP-1 expression has been manifested stronger in in vitro
models.[33] Similar to these results, we found that abdominal
VAT, but not SAT, area was independently associated with levels
of WBC, hsCRP, and NLR.
Interestingly, mean hsCRP levels and WBC counts linearly
decreased in relation to SAT in our study. Although the
association between abdominal SAT area and inﬂammatory
parameters has been controversial thus far, most previous studiesT
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have reported that SAT may have more protective[34,35] function
in endocrine and inﬂammatory aspects than VAT. Further
pathophysiological studies are required to elucidate the exact
relationship between SAT and inﬂammatory markers, consider-
ing the anatomical division of subcutaneous fat between the
superﬁcial (sSAT) and deep (dSAT) layers.
The relationship between chronic low-grade inﬂammation,
insulin resistance, and other obesity-associated metabolic
disturbances has become increasingly recognized,[36] and various
studies have tried to identify sensitive and reliable biomarkers of
oxidative stress and systemic inﬂammation. Because tests for
several serum inﬂammatory markers are inexpensive, widely
available, and easy to interpret, they can serve as simple
indicators of systemic inﬂammation, disease progression, and
health outcomes.[37,38] Levels of WBC and hsCRP are well-
known predictors of CVD,[39] and several epidemiological studies
have linked these markers to various obesity parameters[40] and
cardiovascular risk factors.[7] More recently, NLR and PLR have
received attention as emerging inﬂammatory markers. High
neutrophil and low lymphocyte counts represent the human
physiologic immune response,[41] and platelet count increases
during an acute inﬂammatory reaction.[42] To this end, NLR has
been studied as a potential inﬂammatory biomarker in cardiac
disorders,[43] gastrointestinal diseases, and malignancies,[44]
Figure 2. Inﬂammatory markers according to abdominal fat composition tertiles after adjusting for age, sex, and BMI. Mean (estimated) and standard error
(indicated with error bars).
∗
P< .05 and
∗∗
P< .01 indicate signiﬁcant differences among tertiles using analysis of covariance. †trend P< .05; ††trend P< .01. T, tertile.
A, B, C, D: T1 (24.2–78.4), T2 (79.1–117.2), T3 (117.3–411) cm2; E, F, G, H: T1 (33–196.23), T2 (196.61–287.44), T3 (287.54–1189.11) cm2; I, J, K, L: T1 (0.08–
0.3), T2 (0.3–0.48), T3 (0.48–10.82). hsCRP=high-sensitivity C-reactive protein, NLR=neutrophil-lymphocyte ratio, PLR=platelet-lymphocyte ratio, SAT=
subcutaneous adipose tissue, VAT=visceral adipose tissue, V/S ratio=VAT/SAT ratio; WBC, white blood cell.
Table 3
Multivariate linear regression analysis to determine relationships between abdominal fat parameters and inﬂammatory markers.
WBC count hsCRP NLR PLR
B SE P R2 B SE P R2 B SE P R2 B SE P R2
Model 1
VAT (unit100) 0.743 0.214 .001 0.146 0.715 0.149 < .001 0.259 0.227 0.104 .03 0.028 0.351 0.424 .41 0.075
SAT (unit100) 0.028 0.083 .74 0.006 0.059 .91 0.039 0.04 .33 0.097 0.163 .55
Model 2
V/S (unit1) 0.31 0.146 .03 0.165 0.139 0.104 .18 0.236 0.045 0.072 .53 0.019 0.003 0.292 .99 0.076
All variables left in the model are signiﬁcant at the 0.15 level. No other variable met the 0.15 signiﬁcance level for entry into the model.
Model 1: adjusted for age, sex, BMI, dBP, HDL, LDL, smoking status.
Model 2: adjusted for age, sex, BMI, dBP, TG, HDL, LDL, smoking status.
BMI=body mass index, dBP=diastolic blood pressure, HDL=high-density lipoprotein, hsCRP=high-sensitivity C-reactive protein, LDL= low-density lipoprotein, NLR=neutrophil-lymphocyte ratio, PLR=
platelet-lymphocyte ratio, SAT= subcutaneous adipose tissue, TG= triglycerides, VAT= visceral adipose tissue, V/S=VAT/SAT ratio, WBC=white blood cells.
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while PLR has predicted mortality in patients with malignan-
cies[45] and coronary artery disease.[46] However, the relationship
between NLR and PLR and adiposity had not been investigated
prior to our study. To our knowledge, no previous work has
assessed which inﬂammatory markers are most closely correlated
with abdominal visceral adiposity. We found that WBC and
hsCRP levels are likely associated with visceral adiposity and are
superior to NLR and PLR in this regard.
4.1. Limitations
Our study had several limitations. First, its observational cross-
sectional design did not allow us to assess causality or
temporality, and we could not exclude possible residual
confounding factors. Second, selection bias may have inﬂuenced
our results because the study sample only included data from a
single hospital, which may not be representative of the general
population or other races. Third, we did not assess various
adipokines or pro-inﬂammatory mediators to clarify the
relationship between visceral adiposity and inﬂammatory
processes. Fourth, we did not distinguish dSAT from sSAT
layers in the patients. Despite these limitations, this is the ﬁrst
study to investigate the relationship between multiple inﬂamma-
tory biomarkers and abdominal adiposity precisely evaluated by
CT to predict visceral obesity through comprehensive evaluation
using various statistical approaches.
4.2. Future directions
Future investigations should clarify the possible mechanism
between inﬂammatory markers, fat distribution, and chronic
inﬂammation-related diseases. Also, longitudinal studies with
larger datasets are needed in order to evaluate the best biomarker
visceral obesity.
5. Conclusion
Visceral, but not subcutaneous, adipose tissue area is signiﬁcantly
and independently associated with levels of WBC, hsCRP, and
NLR. In addition, VAT is more strongly correlated with WBC
and hsCRP than with NLR and PLR.
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